View On Demand

Expert Panel On Investigational Treatment for Degenerative Disc Disease

About the Event

Lower back pain caused by degenerative disc disease costs more than $100B in the U.S. alone.

Join our panel discussion to learn more about the challenges presented by lower back pain and the new technologies with the potential to change lives.

  • Kevin T. Foley, M.D., Chairman, Semmes Murphey Neurologic & Spine Institute  
  • Matt O’Brien, Managing Director and Senior Research Analyst at Piper Sandler  
  • Flagg Flanagan, CEO and Chairman, DiscGenics, Inc., a company developing regenerative therapies for patients with degenerative diseases of the spine

DiscGenics has developed a single injection allogenic cell therapy that provides sustained pain relief for patients, thanks to its ability to regenerate disc cells and repair damaged tissue.

View On-Demand


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.